Bayer

Roche shows Tecentriq/Avastin combo helps liver cancer patients live longer
Roche shows Tecentriq/Avastin combo helps liver cancer patients live longer
Endpoints
Roche
Tecentriq
Avastin
liver cancer
China
Bayer
Nexavar
clinical trials
Flag link:
Novartis, Bayer, Longwood back genomics startup to speed search for immunotherapy targets
Novartis, Bayer, Longwood back genomics startup to speed search for immunotherapy targets
Endpoints
Novartis
Bayer
Longwood
immunotherapy
genomics
immuno-oncology
Flag link:
Top 10 pharma settlements since 2018
Top 10 pharma settlements since 2018
Fierce Pharma
settlements
Reckitt Benckiser
JNJ
Bayer
Allergan
Actelion
Purdue Pharma
Teva Pharmaceutical
Endo
Teikoku
Insys
Pfizer
GSK
Astellas
Amgen
Flag link:
Merck and Bayer's heart drug meets main goal of late-stage study
Merck and Bayer's heart drug meets main goal of late-stage study
Yahoo/Reuters
Merck
Bayer
vericiguat
HFrEF
Flag link:
Bayer and Dewpoint Ink Deal for Drugs R&D at New Frontier of Biology
Bayer and Dewpoint Ink Deal for Drugs R&D at New Frontier of Biology
Xconomy
Bayer
Dewpoint Therapeutics
R&D
Flag link:
That $335M JV Bayer set up on CRISPR/Cas9? They’re letting the biotech partner carry on
That $335M JV Bayer set up on CRISPR/Cas9? They’re letting the biotech partner carry on
Endpoints
Bayer
CRISPR Therapeutics
CRISPR-Cas9
Flag link:
Which big pharma firms are best at digital?
Which big pharma firms are best at digital?
Pharmaforum
digital pharma
Bayer
Pfizer
Boehringer Ingelheim
Flag link:
Bayer chooses UK for its AI-focused R&D hub
Bayer chooses UK for its AI-focused R&D hub
Pharmaforum
Bayer
R&D
artificial intelligence
UK
Flag link:
Partner Bayer pushes Ionis' antithrombotic drug into mid-stage development
Partner Bayer pushes Ionis' antithrombotic drug into mid-stage development
Endpoints
Bayer
Ionis Pharmaceuticals
Factor XI
anti-thrombotics
clinical trials
IONIS-FXI-LR
Flag link:
Novartis’ new eye drug undercuts Bayer’s rival with fewer injections
Novartis’ new eye drug undercuts Bayer’s rival with fewer injections
Pharmaforum
Novartis
brolucizumab
Bayer
Eylea
wet age-related macular degeneration
FDA
Flag link:
Recent Job Cuts in the Biopharma Industry
Recent Job Cuts in the Biopharma Industry
BioSpace
Tocagen
Sanofi
Amneal
Daiichi Sankyo
Integra Life Sciences
Aclaris
Bayer
Novartis
Illumina
Merck
Roche Molecular Systems
Prometheus Labs
layoffs
Flag link:
Judge Dismisses ‘White Coat’ Whistleblower Allegations Against Bayer, Eli Lilly
Judge Dismisses ‘White Coat’ Whistleblower Allegations Against Bayer, Eli Lilly
BioSpace
Bayer
Eli Lilly
Humalong
Humulin
diabetes
whistleblower lawsuits
Flag link:
Bayer, Boston academics form joint lab to research lung disease
Bayer, Boston academics form joint lab to research lung disease
Fierce Biotech
Bayer
Brigham and Women's
Massachusetts General Hospital
lung disease
R&D
Flag link:
Bayer’s Vitrakvi is first tumour-agnostic drug approved in EU
Bayer’s Vitrakvi is first tumour-agnostic drug approved in EU
Pharmaforum
Bayer
TRK inhibitors
Vitrakvi
Europe
tumor agnostic drugs
cancer
Flag link:
Novartis backs brolucizumab with new head-to-head Eylea trial
Novartis backs brolucizumab with new head-to-head Eylea trial
Pharmaforum
Novartis
clinical trials
brolucizumab
Eylea
Bayer
Regeneron
age-related macular degeneration
Flag link:
Here's Why Elanco Animal Health Fell 21.1% in August
Here's Why Elanco Animal Health Fell 21.1% in August
Motley Fool
Elanco Health
animal healthy
M&A
Bayer
Flag link:
Does competition equal lower prices? MS drugs defied cost logic as challengers swarmed in
Does competition equal lower prices? MS drugs defied cost logic as challengers swarmed in
Fierce Pharma
multiple sclerosis
MS
drug pricing
Biogen
Roche
Sanofi
Novartis
Teva Pharmaceutical
Bayer
Flag link:
Companies file suit in Canada challenging new rules to lower drug prices
Companies file suit in Canada challenging new rules to lower drug prices
Yahoo/Reuters
drug pricing
Canada
Janssen
Merck
Bayer
Servier
Boehringer Ingelheim
Flag link:
Elanco to buy Bayer's animal health business for $7.6B, as dealmaking gathers steam in the sector
Elanco to buy Bayer's animal health business for $7.6B, as dealmaking gathers steam in the sector
Endpoints
Elanco
Bayer
M&A
animal health
Flag link:
Roche cancer treatment priced at $17,050 a month, lower than rival Vitrakvi
Roche cancer treatment priced at $17,050 a month, lower than rival Vitrakvi
Reuters
Roche
Rozlytrek
Bayer
Eli Lilly
personalized medicine
Flag link:

Pages